483
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Schimke immunoosseous dysplasia: defining skeletal features

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 7 , 28 , 1 , 29 ,
      European Journal of Pediatrics
      Springer-Verlag
      Genocopy, Immunodeficiency, Proteinuria, Skeletal dysplasia, Locus heterogeneity, Schimke immunoosseous dysplasia

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency, and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 ( SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1. We hypothesized that skeletal features distinguish between those with or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of 22 patients with and 11 without detectable SMARCAL1 mutations. We found that patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED) essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the sella turcica, whereas the hands and other long bones are basically normal. Additionally, we found that several of the adolescent and young adult patients developed osteoporosis and coxarthrosis. Of the 11 patients without detectable SMARCAL1 mutations, seven had a SED indistinguishable from patients with SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with SMARCAL1 mutations and that skeletal features do not distinguish who of those with SED have SMARCAL1 mutations.

          Electronic supplementary material

          The online version of this article (doi:10.1007/s00431-009-1115-9) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Genetics of global gene expression.

          A new field of genetic analysis of global gene expression has emerged in recent years, driven by the realization that traditional techniques of linkage and association analysis can be applied to thousands of transcript levels measured by microarrays. Genetic dissection of transcript abundance has shed light on the architecture of quantitative traits, provided a new approach for connecting DNA sequence variation with phenotypic variation, and improved our understanding of transcriptional regulation and regulatory variation.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Genetics of human gene expression: mapping DNA variants that influence gene expression.

            There is extensive natural variation in human gene expression. As quantitative phenotypes, expression levels of genes are heritable. Genetic linkage and association mapping have identified cis- and trans-acting DNA variants that influence expression levels of human genes. New insights into human gene regulation are emerging from genetic analyses of gene expression in cells at rest and following exposure to stimuli. The integration of these genetic mapping results with data from co-expression networks is leading to a better understanding of how expression levels of individual genes are regulated and how genes interact with each other. These findings are important for basic understanding of gene regulation and of diseases that result from disruption of normal gene regulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks.

              Mutations in SMARCAL1 (HARP) cause Schimke immunoosseous dysplasia (SIOD). The mechanistic basis for this disease is unknown. Using functional genomic screens, we identified SMARCAL1 as a genome maintenance protein. Silencing and overexpression of SMARCAL1 leads to activation of the DNA damage response during S phase in the absence of any genotoxic agent. SMARCAL1 contains a Replication protein A (RPA)-binding motif similar to that found in the replication stress response protein TIPIN (Timeless-Interacting Protein), which is both necessary and sufficient to target SMARCAL1 to stalled replication forks. RPA binding is critical for the cellular function of SMARCAL1; however, it is not necessary for the annealing helicase activity of SMARCAL1 in vitro. An SIOD-associated SMARCAL1 mutant fails to prevent replication-associated DNA damage from accumulating in cells in which endogenous SMARCAL1 is silenced. Ataxia-telangiectasia mutated (ATM), ATM and Rad3-related (ATR), and DNA-dependent protein kinase (DNA-PK) phosphorylate SMARCAL1 in response to replication stress. Loss of SMARCAL1 activity causes increased RPA loading onto chromatin and persistent RPA phosphorylation after a transient exposure to replication stress. Furthermore, SMARCAL1-deficient cells are hypersensitive to replication stress agents. Thus, SMARCAL1 is a replication stress response protein, and the pleiotropic phenotypes of SIOD are at least partly due to defects in genome maintenance during DNA replication.
                Bookmark

                Author and article information

                Contributors
                +1-604-8752157 , +1-604-8752376 , boerkoel@interchange.ubc.ca
                Journal
                Eur J Pediatr
                European Journal of Pediatrics
                Springer-Verlag (Berlin/Heidelberg )
                0340-6199
                1432-1076
                15 December 2009
                15 December 2009
                July 2010
                : 169
                : 7
                : 801-811
                Affiliations
                [1 ]Child and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, BC Canada
                [2 ]Department of Pediatrics, Hannover Medical School, Hannover, Germany
                [3 ]University Children’s Hospital, Mainz, Germany
                [4 ]Department of Clinical Genetics, St Michael’s Hospital, Bristol, UK
                [5 ]Pediatric Nephrology, Marmara University, Istanbul, Turkey
                [6 ]Néphrologie Pédiatrique, Hopital d’Enfants, Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy Cedex, France
                [7 ]Department of Endocrinology & Metabolism, Kanagawa Children’s Medical Center, Yokohama, Japan
                [8 ]Institute of Mother and Child Health Care of Serbia, Belgrade, Serbia
                [9 ]Service de Genetique Medicale, Centre Hospitalier Universitaire d’Angers, Angers, France
                [10 ]Department of Radiology, University of British Columbia, Vancouver, BC Canada
                [11 ]Department of Pediatric Nephrology, Erasmus MC-Sophia, Rotterdam, The Netherlands
                [12 ]KfH Kinderdialyse, Münster, Germany
                [13 ]Department of Medical Genetics, “Aghia Sophia” Children’s Hospital, Athens University Medical School, Athens, Greece
                [14 ]Department of Pathology, School of Medicine, University of North Carolina, Chapel Hill, NC USA
                [15 ]Department of Pediatric Radiology, University of Hamburg, Hamburg, Germany
                [16 ]Karolinska University Hospital, Stockholm, Sweden
                [17 ]Department of Pediatrics, University of Naples, Naples, Italy
                [18 ]Mercy Pediatrics and Adolescent Clinic, Clear Lake, IA USA
                [19 ]Pediatric Nephrology, Assistance Publique-Hopitaux de Paris, Hopital Robert Debre, Paris, France
                [20 ]Medical Genetics, Department of Experimental Medicine and Pathology, S. Camillo–Forlanini Hospital, University La Sapienza, Rome, Italy
                [21 ]Southcrest Family and Maternity Care, Tulsa, OK USA
                [22 ]Children’s Hospital, Technical University, Munich, Germany
                [23 ]Medical Genetics Centre, St. Mary Hospital of Iasi, Iasi, Romania
                [24 ]Consulta de Genética, Hospital Pediátrico de Coimbra, Coimbra, Portugal
                [25 ]Children’s Hospital, University of Cologne, Cologne, Germany
                [26 ]Division of Nephrology, Department of Pediatrics, Kosair Children’s Hospital, School of Medicine, University of Louisville, Louisville, KY USA
                [27 ]Département de Génétique Médicale, Hôpital Timone Enfant, Marseille, France
                [28 ]Department of Pediatrics, King Faisal Specialist Hospital and Research Centre-Jeddah, Jeddah, Saudi Arabia
                [29 ]Department of Medical Genetics, Children’s and Women’s Health Centre of BC, 4500 Oak St., Rm. C234, Vancouver, BC Canada V6H 3N1
                Article
                1115
                10.1007/s00431-009-1115-9
                2876264
                20013129
                9bdc8a68-48ac-44c2-a43f-990b9957ddea
                © The Author(s) 2009
                History
                : 10 September 2009
                : 17 November 2009
                Categories
                Original Paper
                Custom metadata
                © Springer-Verlag 2010

                Pediatrics
                skeletal dysplasia,locus heterogeneity,genocopy,proteinuria,immunodeficiency,schimke immunoosseous dysplasia

                Comments

                Comment on this article